KYORIN Pharmaceutical Co., Ltd. (TYO:4569)

KYORIN Pharmaceutical Revenue

In the fiscal year ending March 31, 2026, KYORIN Pharmaceutical had annual revenue of 126.26B JPY, down -2.94%. KYORIN Pharmaceutical had revenue of 33.80B in the quarter ending March 31, 2026, a decrease of -17.16%.

• Revenue: 126.26B
• Revenue Growth: -2.94%
• P/S Ratio: 0.58
• Revenue / Employee: 63.19M
• Employees: 1,998
• Market Cap: 72.73B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	126.26B	-3.83B	-2.94%
Mar 31, 2025	130.09B	10.56B	8.83%
Mar 31, 2024	119.53B	6.26B	5.53%
Mar 31, 2023	113.27B	7.74B	7.33%
Mar 31, 2022	105.53B	2.63B	2.56%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 28, 2026

Data Sources Report a data error